Home » Authors » Christopher Delporte

Articles by Christopher Delporte

Life after DES: The search for the next blockbuster product

May 1, 2005

By Christopher Delporte

Leavitt outlines government’s ‘convenor’ role in healthcare IT

April 29, 2005

By Christopher Delporte

Stem cell research guidelines offered by National Academies

April 27, 2005

By Christopher Delporte

Panel hails Cardica’s PAS-Port but says more data is needed

April 26, 2005

By Christopher Delporte

AdvaMed: ‘significant changes’ produced by its ethics code

April 22, 2005

By Christopher Delporte

New AHRQ initiative could impact use of device therapies

April 19, 2005

By Christopher Delporte

Panel’s split decision leaves industry wondering what’s next

April 15, 2005

By Christopher Delporte

CMS funds back small-practice adoption of EHR technology

April 14, 2005

By Christopher Delporte

Inamed falls short in its bid to lift the FDA’s ban on product

April 14, 2005

By Christopher Delporte

By a 7-2 vote, Mentor earns an ‘approvable’ recommendation

April 14, 2005

By Christopher Delporte

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...